Literature DB >> 20810453

Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanning.

Catriona Goodlad1, Ruth Tarzi, Wladyslaw Gedroyc, Adrian Lim, Steven Moser, Edwina A Brown.   

Abstract

BACKGROUND: We previously validated a scoring system for abdominal/pelvic CT scans in patients with symptomatic encapsulating peritoneal sclerosis (EPS). CT scans of patients with symptomatic EPS were significantly different from control peritoneal dialysis (PD) or haemodialysis patient scans; scans performed before EPS was clinically evident were near normal in 9 of 13 patients. We have now investigated CT scanning as a screening modality in a larger group of patients on long-term PD.
METHODS: Pre-diagnostic CT scans performed in 20 patients for routine screening or other indications at least 3 months before EPS developed, and later diagnostic scans when EPS was clinically evident, were scored by three radiologists. The control group included CT scans of 20 PD patients who had not developed EPS (median follow-up 2.25 years). Analysis was by non-parametric tests. CT scores ranged from 0 to 22; > 2.5 was considered abnormal.
RESULTS: Clinical EPS only developed after transplantation or transfer to HD. Diagnostic scans scored significantly higher than pre-diagnostic or control scans (median scores 9, 2 and 1; P < 0.001), confirming previous work. The pre-EPS diagnosis of 12 asymptomatic patients had a median CT score = 1.75, similar to the control group. Eight patients had had a limited episode of abdominal symptoms (seven required hospitalization), but did not have the clinical picture of EPS; their median CT score was 4.5 (P = 0.0016 cf control group). The time from pre-diagnostic scan to clinical EPS (median 0.82 years) and duration of PD at time of pre-diagnostic scan (median 7.1 years) did not differ significantly between the symptomatic and asymptomatic groups.
CONCLUSIONS: CT screening of asymptomatic PD patients is not indicated; EPS may occur within a year or less of a normal CT scan. Abdominal symptoms in long-term PD patients can be associated with CT scan abnormalities; these patients are at increased risk of EPS after stopping PD.

Entities:  

Mesh:

Year:  2010        PMID: 20810453     DOI: 10.1093/ndt/gfq533

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

1.  Towards standardized reporting in studies of encapsulating peritoneal sclerosis.

Authors:  Mark Lambie; Niko Braun; Simon J Davies
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

Review 2.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

Review 3.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

4.  American Society of Nephrology quiz and questionnaire 2012: renal replacement therapy.

Authors:  Rajnish Mehrotra; Richard J Glassock; Anthony J Bleyer
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

5.  Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis.

Authors:  Yuk-Yi Wong; Ping-Nam Wong; Siu-Ka Mak; Shuk-Fan Chan; Yuen-Yi Cheuk; Lo-Yi Ho; Kin-Yee Lo; Man-Wai Lo; Kwok-Chi Lo; Gensy Mei-Wah Tong; Andrew Kui-Man Wong
Journal:  Perit Dial Int       Date:  2013-08-01       Impact factor: 1.756

6.  CD147 expression in peritoneal injury.

Authors:  Harald Seeger; Joerg Latus; Daniel Kitterer; M Dominik Alscher; Dagmar Biegger; Jin Chen; Ilka Edenhofer; Rudolf P Wüthrich; Stephan Segerer
Journal:  Clin Exp Nephrol       Date:  2017-05-27       Impact factor: 2.801

7.  Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis.

Authors:  Catriona Goodlad; Frederick W K Tam; Sohail Ahmad; Gurjeet Bhangal; Bernard V North; Edwina A Brown
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

8.  Histological criteria for encapsulating peritoneal sclerosis - a standardized approach.

Authors:  Niko Braun; Peter Fritz; Christoph Ulmer; Joerg Latus; Martin Kimmel; Dagmar Biegger; German Ott; Fabian Reimold; Klaus-Peter Thon; Juergen Dippon; Stephan Segerer; M Dominik Alscher
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  C-reactive protein levels in combination with abdominal CT scans is a useful tool to predict the macroscopic appearance in late-stage EPS patients prior to surgery.

Authors:  Daniel Kitterer; Stephan Segerer; Wolfgang Steurer; Juergen Dippon; Angela Geissler; Christoph Ulmer; Niko Braun; Mark Dominik Alscher; Joerg Latus
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-08-13

Review 10.  Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease.

Authors:  Zia Moinuddin; Angela Summers; David Van Dellen; Titus Augustine; Sarah E Herrick
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.